In our study, the rate of cases with PSMA labelling index 2 was higher than in the previous report for pleomorphic liposarcoma (25% vs. 10%), undifferentiated soft tissue sarcoma (65% vs. 18.2%). This evidence concerns the gene FOLH1 and pleomorphic liposarcoma.